{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "licensed-patents", "type": "definition", "offset": [38, 54]}, {"key": "field-of-use", "type": "definition", "offset": [91, 103]}], "samples": [{"hash": "evbWmWmYbeS", "uri": "/contracts/evbWmWmYbeS#covered-technology", "label": "Exclusive License Agreement (Rain Enhancement Technologies Holdco, Inc.)", "score": 36.0171115674, "published": true}, {"hash": "cLiBspDtWcK", "uri": "/contracts/cLiBspDtWcK#covered-technology", "label": "Exclusive License Agreement (dMY Technology Group, Inc. VI)", "score": 33.9938398357, "published": true}], "size": 2, "snippet": "means all technology described in the Licensed Patents that has any application within the Field of Use.", "hash": "19e93e4b0afb8011262e45afc153ade7", "id": 1}, {"snippet_links": [{"key": "the-intellectual-property", "type": "definition", "offset": [6, 31]}, {"key": "by-codexis", "type": "clause", "offset": [41, 51]}, {"key": "pursuant-to-section", "type": "clause", "offset": [61, 80]}, {"key": "for-purposes-of-clarification", "type": "clause", "offset": [94, 123]}, {"key": "other-technology", "type": "clause", "offset": [193, 209]}, {"key": "license-grants", "type": "definition", "offset": [228, 242]}, {"key": "section-21", "type": "clause", "offset": [246, 257]}, {"key": "agreement-or", "type": "definition", "offset": [273, 285]}, {"key": "section-45", "type": "clause", "offset": [286, 297]}, {"key": "ie-agreement", "type": "definition", "offset": [305, 317]}, {"key": "shell-agreement", "type": "definition", "offset": [326, 341]}], "samples": [{"hash": "dBDTpCTSBtd", "uri": "/contracts/dBDTpCTSBtd#covered-technology", "label": "License Agreement (Codexis Inc)", "score": 23.8501026694, "published": true}, {"hash": "asbh8drhK5D", "uri": "https://www.codexis.com/investors/sec-filings/all-sec-filings/content/0001193125-12-457399/0001193125-12-457399.pdf", "label": "www.codexis.com", "score": 8.4099931554, "published": false}], "size": 2, "snippet": "means the intellectual property licensed by Codexis to Shell pursuant to Section 4.2(a) only. For purposes of clarification, \u201cCovered Technology\u201d shall not include any intellectual property or other technology covered under the license grants in Section 2.1 of the License Agreement or Section 4.5 of the IE Agreement/Codexis/Shell Agreement.", "hash": "4c8214c4daaa51005a3c10ba9599bb2c", "id": 2}, {"snippet_links": [{"key": "transferred-technology", "type": "definition", "offset": [14, 36]}, {"key": "trade-secrets", "type": "definition", "offset": [72, 85]}, {"key": "intellectual-property-rights-and-improvements", "type": "clause", "offset": [118, 163]}], "samples": [{"hash": "bQpQJqwOHtU", "uri": "/contracts/bQpQJqwOHtU#covered-technology", "label": "Membership Interests and Asset Purchase Agreement", "score": 29.340862423, "published": true}, {"hash": "apjygiXTAMv", "uri": "/contracts/apjygiXTAMv#covered-technology", "label": "Membership Interest and Asset Purchase Agreement (Catalytica Energy Systems Inc)", "score": 21.0, "published": true}], "size": 2, "snippet": "means (a) all Transferred Technology, (b) all Improvements, and (c) all Trade Secrets included within the Transferred Intellectual Property Rights and Improvements.", "hash": "cf13365a5c496f4dae124010e2dd4c2a", "id": 3}, {"snippet_links": [{"key": "property-used", "type": "clause", "offset": [23, 36]}, {"key": "tangible-property", "type": "definition", "offset": [62, 79]}, {"key": "property-improvements", "type": "clause", "offset": [93, 114]}, {"key": "field-of-use", "type": "definition", "offset": [127, 139]}, {"key": "a-valid-claim", "type": "clause", "offset": [204, 217]}, {"key": "licensed-patent-rights", "type": "definition", "offset": [221, 243]}, {"key": "for-the-purpose-of-this-agreement", "type": "clause", "offset": [325, 358]}, {"key": "patent-claim", "type": "clause", "offset": [382, 394]}, {"key": "issued-patent", "type": "definition", "offset": [401, 414]}, {"key": "the-licensed-patent", "type": "clause", "offset": [431, 450]}, {"key": "in-the-event", "type": "clause", "offset": [525, 537]}, {"key": "rights-hereunder", "type": "clause", "offset": [598, 614]}, {"key": "court-of-competent-jurisdiction", "type": "definition", "offset": [659, 690]}, {"key": "final-decision", "type": "clause", "offset": [696, 710]}, {"key": "an-appeal", "type": "clause", "offset": [722, 731]}, {"key": "for-the-purposes-of-this-agreement", "type": "clause", "offset": [798, 832]}, {"key": "effective-as-of-the", "type": "clause", "offset": [834, 853]}, {"key": "date-of", "type": "clause", "offset": [854, 861]}, {"key": "in-scope", "type": "definition", "offset": [1019, 1027]}, {"key": "in-accordance-with", "type": "definition", "offset": [1028, 1046]}], "samples": [{"hash": "dR56NRzEBBI", "uri": "/contracts/dR56NRzEBBI#covered-technology", "label": "Non Exclusive Sublicense Agreement (Pharmasset Inc)", "score": 21.0, "published": true}, {"hash": "cMVs4ZuA2HC", "uri": "/contracts/cMVs4ZuA2HC#covered-technology", "label": "Sublicense Agreement (Pharmasset Inc)", "score": 21.0, "published": true}], "size": 2, "snippet": "means any Intellectual Property used by Pharmasset (including Tangible Property and Tangible Property Improvements) within the Field of Use that (i) in the absence of a license from Apath, would infringe a Valid Claim of Licensed Patent Rights and/or (ii) involves a use thereof permitted to Pharmasset under this Agreement. For the purpose of this Agreement, \u201cValid Claim\u201d means a patent claim in an issued patent included within the Licensed Patent Rights which has not been disclaimed or canceled; provided, however, that in the event any claim of a patent that falls within the Licensed Patent Rights hereunder shall be held invalid or not infringed by a court of competent jurisdiction in a final decision from which an appeal cannot be or is not taken, or certiorari cannot be granted, then, for the purposes of this Agreement, effective as of the date of such final decision, such claim held invalid shall be considered canceled from such patent and any such claim held not infringed shall be considered limited in scope in accordance with such final decision.", "hash": "a4b798753a7b5fed437b2eb4ad45d2ab", "id": 4}, {"snippet_links": [{"key": "electronic-communication", "type": "definition", "offset": [10, 34]}, {"key": "social-media", "type": "definition", "offset": [38, 50]}, {"key": "for-the-purposes-of", "type": "clause", "offset": [52, 71]}, {"key": "this-policy", "type": "definition", "offset": [72, 83]}], "samples": [{"hash": "brgngEadGiI", "uri": "http://www.pcasaints.org/wp-content/uploads/2014/03/Electronic-Communication-and-Social-Media-Policy.docx", "label": "www.pcasaints.org", "score": 7.6611909651, "published": false}], "size": 2, "snippet": "means any Electronic Communication or Social Media. For the purposes of this Policy, Covered Technology shall not include any School-Sponsored Technology.", "hash": "6ce1398d748ebda16439463fc9054ede", "id": 5}, {"snippet_links": [{"key": "assigned-technology", "type": "definition", "offset": [10, 29]}, {"key": "sublicensed-technology", "type": "definition", "offset": [38, 60]}], "samples": [{"hash": "4UtzKQYVXoG", "uri": "/contracts/4UtzKQYVXoG#covered-technology", "label": "Asset Transfer and Sublicense Agreement (Enchira Biotechnology Corp)", "score": 21.0, "published": true}], "size": 1, "snippet": "means the Assigned Technology and the Sublicensed Technology.", "hash": "5ff5b34471405087db760ec22198660b", "id": 6}, {"snippet_links": [{"key": "relate-to", "type": "definition", "offset": [23, 32]}, {"key": "the-business", "type": "clause", "offset": [56, 68]}, {"key": "if-required", "type": "definition", "offset": [99, 110]}, {"key": "in-case-of", "type": "clause", "offset": [116, 126]}, {"key": "deep-cleaning", "type": "definition", "offset": [367, 380]}, {"key": "preparation-for", "type": "clause", "offset": [469, 484]}, {"key": "active-ingredients", "type": "definition", "offset": [524, 542]}, {"key": "final-inspection", "type": "clause", "offset": [879, 895]}, {"key": "packaging-for-shipment", "type": "clause", "offset": [900, 922]}, {"key": "based-on", "type": "clause", "offset": [931, 939]}, {"key": "transferred-intellectual-property-rights", "type": "definition", "offset": [944, 984]}, {"key": "listed-below", "type": "clause", "offset": [1000, 1012]}, {"key": "yes-yes", "type": "clause", "offset": [1129, 1136]}, {"key": "patent-ownership", "type": "clause", "offset": [1137, 1153]}, {"key": "in-the-process", "type": "definition", "offset": [1154, 1168]}], "samples": [{"hash": "jFd1Elk7hxv", "uri": "/contracts/jFd1Elk7hxv#covered-technology", "label": "Settlement Agreement (Catalytica Energy Systems Inc)", "score": 21.0, "published": true}], "size": 1, "snippet": "means Technology which relate to the following steps of the Business: \u2022 Disassembling the modules (if required e.g. in case of some multi-layer plate or corrugated plate catalyst) and mechanical cleaning (ash removal and vacuuming, especially in between plate layers); \u2022 Soaking the catalyst in a water-based solution at a controlled pH and temperature; \u2022 Ultrasonic deep cleaning in a water-based solution at a controlled pH, temperature, agitation, and movement as a preparation for further treatment and replenishment of active ingredients; \u2022 Neutralization in a water-based solution at a controlled pH and temperature; \u2022 Multi-stage rinsing in DI water at a controlled temperature and conductivity; \u2022 Drying the clean catalyst; \u2022 Replenishing active ingredients in a concentration- and temperature-controlled DI water-based solution; \u2022 Drying the regenerated catalyst; and \u2022 Final inspection and packaging for shipment. and is based on the transferred intellectual property rights from ENVICA as listed below: DE 198 29 916 US: 6,241,826 Can: 2,336,562 Patent granted Process for regenerating catalytic converters 06.07.1998 yes yes Patent ownership in the process of being transferred to ENVICA GmbH. DE 102 41 004.6 US: Yes Can: Yes None Process for the regeneration of iron contaminated denitrifying catalysts 05.09.2002 yes yes The earliest possible time for National Phases is May 2004. With international examination Request further 10 months later. DE 102 42 081.5 US: Yes Can: Yes None Process for regeneration of denitrifying catalysts contaminated by phosphorus 11.09.2002 yes yes The earliest possible time for National Phases is May 2004. With international examination Request further 10 months later.", "hash": "005d8ffba2389e410d6ecd8f9bb162fd", "id": 7}, {"snippet_links": [{"key": "proposed-rules", "type": "definition", "offset": [234, 248]}], "samples": [{"hash": "bBQ8d7bYqUo", "uri": "https://www.nasaa.org/wp-content/uploads/2023/09/Complete_with_DocuSign_20231204_Robinhood_pd.pdf", "label": "www.nasaa.org", "score": 13.5435098981, "published": false}], "size": 1, "snippet": "means \u201can analytical, technological, or computational function, algorithm, model, correlation matrix, or similar method or process that optimizes for, predicts, guides, forecasts, or directs investment-related behaviors or outcomes.\u201d Proposed Rules 15l- 2(a), 211(h)(2); Proposing Release, 88 Fed. Reg. at 54,021-22, 54,023.", "hash": "b87d076f6f0732059497021e04762416", "id": 8}, {"snippet_links": [{"key": "improvements-and-modifications", "type": "definition", "offset": [32, 62]}], "samples": [{"hash": "iJs3Pqz91Am", "uri": "/contracts/iJs3Pqz91Am#covered-technology", "label": "License Agreement (RTI Biologics, Inc.)", "score": 19.0, "published": true}], "size": 1, "snippet": "means (i) **********, including improvements and modifications thereto, used by RTI or its Affiliates in the past, present, or future; **********.", "hash": "329fb4fe3b1973a545cd8f208e87fd12", "id": 9}, {"snippet_links": [{"key": "section-921", "type": "clause", "offset": [14, 27]}, {"key": "this-agreement", "type": "clause", "offset": [31, 45]}], "samples": [{"hash": "bpCYkbAKcZl", "uri": "/contracts/bpCYkbAKcZl#covered-technology", "label": "Letter Agreement (Clearwire Corp /DE)", "score": 22.5879534565, "published": true}], "size": 1, "snippet": "is defined in Section 9.2.1 of this Agreement.", "hash": "38970becdde7a1a0064f892531bbf89b", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIbY292ZXJlZC10ZWNobm9sb2d5IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 17, "snippet": "means all technology described in the Licensed Patents that has any application within the Field of Use.", "title": "Covered Technology", "id": "covered-technology", "examples": ["For the life of the Patents, Purchaser (on behalf of itself and any assignees) also covenants not to rely on any of Seller\u2019s <strong>Covered Technology</strong> (in whole or in part) to meet any element of any infringement claim of the Patents against Seller, its Subsidiaries or any third party.", "The Asset Sellers and their Affiliates shall not use the <strong>Covered Technology</strong> for regeneration of SCR catalysts that to the Knowledge of the Asset Sellers are intended for use in the NAFTA Territories.", "The covenants not to \u2587\u2587\u2587 entered into under this Agreement are effective as set forth in Section 2 and continue until the last sale of a Masimo Covered Product or product including Mindray <strong>Covered Technology</strong> anywhere in the world, unless terminated pursuant to Section 3.1.", "Subject to the terms and conditions of this Agreement, Apath hereby grants to Pharmasset, and Pharmasset hereby accepts, a non-exclusive, non-transferable sublicense (without the right to sublicense others) under the Intellectual Property to make (i.e., replicate), use (but not sell or for any other commercial purpose) and practice <strong>Covered Technology</strong> encompassed by the Intellectual Property.", "Without limiting the generality of the foregoing, each Asset Seller shall, and shall cause each of its respective Affiliates to protect the confidentiality of the <strong>Covered Technology</strong> by using the same degree of care to prevent the unauthorized use, dissemination, or publication of the <strong>Covered Technology</strong> as such Asset Seller uses to protect its other confidential information, but no less than a reasonable degree of care.", "Buyer agrees to promptly inform the Asset Sellers in writing of any disclosure of the <strong>Covered Technology</strong>, whether intentional or not, which violates the provisions of this Section 11.16(b).", "Buyer further agrees that it will not disclose, and will cause each of its Affiliates not to disclose, the <strong>Covered Technology</strong> to any person, except to its employees, contractors, or agents who need to know the <strong>Covered Technology</strong> and have signed a non-use and non-disclosure agreement with obligations no less stringent than the obligations of this Section 11.16(b) prior to any disclosure of the <strong>Covered Technology</strong>.", "Without limiting the generality of the foregoing, Buyer shall, and shall cause each of its Affiliates to protect the confidentiality of the <strong>Covered Technology</strong> by using the same degree of care to prevent the unauthorized use, dissemination, or publication of the <strong>Covered Technology</strong> as Buyer uses to protect its other confidential information, but no less than a reasonable degree of care.", "Each Asset Seller further agrees that it will not disclose, and will cause each of its Affiliates not to disclose, the <strong>Covered Technology</strong> to any person, except to its employees, contractors, or agents who need to know the <strong>Covered Technology</strong> and have signed a non-use and non-disclosure agreement with obligations no less stringent than the obligations of this Section 11.16(d) prior to any disclosure of the <strong>Covered Technology</strong>.", "Each Asset Seller agrees to promptly inform Buyer in writing of disclosure of the <strong>Covered Technology</strong>, whether intentional or not, which violates the provisions of this Section 11.16(d)."], "related": [["transferred-technology", "Transferred Technology", "Transferred Technology"], ["developed-technology", "Developed Technology", "Developed Technology"], ["licensed-technology", "Licensed Technology", "Licensed Technology"], ["company-technology", "Company Technology", "Company Technology"], ["third-party-technology", "Third Party Technology", "Third Party Technology"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}